atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook Jan 13, 2023
Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
Lobe Sciences Hopes To Move Novel Psilocin Drug Compounds Quickly Through The FDA Funnel Nov 22, 2022
